Martin Shkreli's KaloBios Pharmaceuticals files for bankruptcy
Wednesday, December 30, 2015 - 08:00
in Mathematics & Economics
Andrew V. PestanoDOVER, Del., Dec. 30 (UPI) -- KaloBios Pharmaceuticals Inc., the company where infamous biotech investor Martin Shkreli was recently fired as CEO, filed for Chapter 11 bankruptcy.